Novo Nordisk launches Wegovy in India, targets obesity treatment...

Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection

Posted

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

Entertainment

Diddy praises judge Subramanian for 'excellent job'

Sean "Diddy" Combs, facing sex trafficking charges, has decided not to testify in his trial,...

By 0 1

Entertainment

Paresh Rawal's wife once called him dumb for THIS

Paresh Rawal, celebrated for his comedic and villainous roles in Bollywood, shares a charming...

By 0 1

Entertainment

Orlando and Katy SPLIT after nearly a decade together

Orlando Bloom and Katy Perry have reportedly ended their nearly decade-long relationship, amidst...

By 0 1

Entertainment

Makers Sardaar Ji 3 issue statement amid Hania's row

Amidst controversy surrounding Hania Aamir's casting in 'Sardaar Ji 3' post-Pahalgam attack, the...

By 0 1

Sports

'Pushed into deep sea, but he’ll swim'- Gambhir on Gill’s first Test as captain

Gautam Gambhir has urged critics to give Shubman Gill time to prove himself as India's Test...

By 0 4